LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
for Ulcerative Colitis (UC)
50 locations incl. Phoenix
Sponsor: Eli Lilly and Company
Sex: All·Age: 18 - 80
Code: NCT07415044·Phase 2·Recruiting·Listed Feb 2026
Gastro Intestinal Research Institute of Northern Ohio, LLC
Clinical research site in Westlake, Ohio · Clinical Research Institute of Ohio, 850 Columbia Rd #200, Westlake, OH 44145 · (440) 363-4000 · Website
As of July 2026, 9 paid clinical trials are recruiting at Gastro Intestinal Research Institute of Northern Ohio, LLC in Westlake, Ohio. Active studies at this site cover conditions such as Obesity or Overweight, Colitis, Ulcerative and Crohn's Disease. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at Gastro Intestinal Research Institute of Northern Ohio, LLC (9)
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
for Ulcerative Colitis
39 locations incl. Dothan
Sponsor: Takeda
Sex: All·Age: 18 - 65
Code: NCT06095128·Phase 4·Recruiting·Listed Oct 2023
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
for Crohn's Disease
42 locations incl. Dothan
Sponsor: Takeda
Sex: All·Age: 18 - 70
Code: NCT06045754·Phase 4·Recruiting·Listed Sep 2023
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
for Moderately to Severely Active Crohns Disease
92 locations incl. Dothan
Sponsor: Hoffmann-La Roche
Sex: All·Age: 16 - 80
Code: NCT06819878·Phase 3·Recruiting·Listed Feb 2025
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
for Ulcerative Colitis
37 locations incl. Dothan
Sponsor: Eli Lilly and Company
Sex: All·Age: 18 - 70
Code: NCT06937086·Phase 3·Recruiting·Listed Apr 2025
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
for Crohn's Disease
35 locations incl. Dothan
Sponsor: Eli Lilly and Company
Sex: All·Age: 18 - 70
Code: NCT06937099·Phase 3·Recruiting·Listed Apr 2025
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
for Colitis, Ulcerative
27 locations incl. Mesa
Sponsor: Pfizer
Sex: All·Age: 18 - 64
Code: NCT06398626·Recruiting·Listed May 2024
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis
for Moderately to Severely Active Ulcerative Colitis
70 locations incl. Dothan
Sponsor: Hoffmann-La Roche
Sex: All·Age: 16 - 80
Code: NCT06588855·Phase 3·Recruiting·Listed Sep 2024
ALPCO Calprotectin CLIA Assay - Measurement of Calprotectin Levels in Human Stool
for Inflammatory Bowel Disease (Crohn'
3 locations incl. Miami
Sponsor: American Laboratory Products Company
Sex: All·Age: 22+·Accepts healthy volunteers
Code: NCT06810518·Recruiting·Listed Feb 2025
More research sites in Westlake
- UH Seidman Cancer Center at Saint John Medical Center (11 trials)
- UHHS-Westlake Medical Center (5 trials)
- North Shore Gastroenterology Research (4 trials)
- Gastro Intestinal Research Institute of Northern Ohio (3 trials)
- 89bio Clinical Study Site (2 trials)
- Akero Clinical Study Site (2 trials)
- CRIOH (2 trials)
- Gastro Intestinal Research Institute of Northern Ohio, LLC. (2 trials)
- Northshore Gastroenterology Research (2 trials)
- Altimmune Clinical Study Site (1 trial)